<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The benefit of antithymocyte globulin in severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in the pediatric age group was assessed </plain></SENT>
<SENT sid="1" pm="."><plain>Four children received ten alternate-day courses of ATG (horse antihuman thymocyte globulin) as well as <z:chebi fb="5" ids="37956">antihistamines</z:chebi> and <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> to minimize allergic reactions </plain></SENT>
<SENT sid="2" pm="."><plain>The outcome of 19 other children with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> who received ATG was also summarized </plain></SENT>
<SENT sid="3" pm="."><plain>Combined data reveal that 12 of 23 have had a complete or partial response with residual <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and a probability of 48% survival one year from the start of ATG therapy as projected by life table analysis </plain></SENT>
<SENT sid="4" pm="."><plain>Only one <z:hpo ids='HP_0011420'>death</z:hpo> has been recorded in the responding group </plain></SENT>
<SENT sid="5" pm="."><plain>Response rate did not appear to be influenced by age, sex, etiology, initial blood count, interval prior to ATG therapy, or dose of ATG employed </plain></SENT>
<SENT sid="6" pm="."><plain>Complications were minimal and included minor urticarial reactions and <z:hpo ids='HP_0001954'>intermittent fever</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Therapy with ATG should be considered in childhood severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> when bone marrow transplantation is not possible </plain></SENT>
</text></document>